Overview
The purpose of this study is to determine the effect of a dietary supplement rich in nitric oxide (NO) on nasal nitric oxide and fractional exhaled nitric oxide (FeNO),on ciliary beat frequency assessed by high-speed digital video microscopy and on lung function assessed by spirometry in normal patients and patients with Primary ciliary dyskinesia (PCD).
Eligibility
Inclusion Criteria:
Experimental group:
- PCD patients
Control Group:
- patients with no known chronic lung disease
- 18 years to 99 years
Exclusion Criteria(both PCD patients and control group):
- any other pulmonary co-morbidities and diseases entities like cystic fibrosis, nasal sinus surgery, nasal sinus hypoplasia/aplasia, deviated nasal septum, nasal polyps and with upper respiratory tract infection
- patients allergic to beet
- a known prolonged bleeding disorder.